Sign in Subscribe

Gregg Boyle

Nashville

The Federal Floor Just Moved Down. Everyone Else Is Moving Up.

The Federal Floor Just Moved Down. Everyone Else Is Moving Up.

This week the regulatory map redrew itself, and in opposite directions in adjacent agencies. HHS proposed rolling back AI health IT transparency requirements that have been the floor for vendor accountability since 2024. The FDA cleared the first continuous AI sepsis monitoring system with an 18% mortality reduction endpoint. MACPAC

From Pilot to Practice: The Operationalization Quarter Begins

From Pilot to Practice: The Operationalization Quarter Begins

Executive Read For operators, this week's signal is unambiguous. Ambient AI is no longer the question, workforce redesign around AI, clinical and back-office, is. Four deployment data points landed at named systems with documented achieved metrics, and they describe the new procurement reality. Abridge made nursing AI

The Regulator Just Moved the Map

The Regulator Just Moved the Map

This week, the regulator wrote the script. FDA opened the door on AI-monitored real-time clinical trials with named pharma collaborators. Science published peer-reviewed evidence of physician-level LLM reasoning. OpenEvidence, reportedly used by 40% of US physicians, pulled its product from the EU and UK over AI

The Carrot and the Stick Arrived Together

The Carrot and the Stick Arrived Together

While many still chased ambient AI headlines, the FDA, CMS, and a half-dozen state regulators continued to write the rules that determine which AI gets paid for, which gets enforced against, and which gets pulled. Procurement committees will now have a different rubric to use. Health systems already operating

AI is On the Path to Becoming a Regulated Category.

AI is On the Path to Becoming a Regulated Category.

This week the regulatory scaffolding for American healthcare AI arrived in a single five-day stretch. NCCN embedded an AI-derived risk threshold in cancer screening guidelines. FDA validated its first AI drug development tool. CMS wrote a national reimbursement pathway for a specific AI model. HSCC, IMDRF, ACCME, and

The New Rules of Healthcare AI Are Here: Reimbursement, Regulation, and Real Proof

The New Rules of Healthcare AI Are Here: Reimbursement, Regulation, and Real Proof

This week the healthcare AI landscape crossed a threshold. CMS created a reimbursement code for AI-detected coronary calcium. The FDA signaled it is moving toward post-market oversight. Four states advanced therapy chatbot bans. The WISeR Medicare pilot launched AI-powered claims review. And Q1 digital health funding hit

The proof era has arrived: AI claims are now being tested like drugs, and health systems are paying attention.

The proof era has arrived: AI claims are now being tested like drugs, and health systems are paying attention.

This week it looks as if the era of vendor-led proof points is ending. Peer-reviewed trials, multicenter studies, and scale decisions driven by documented outcomes are replacing the pilot press release. Procurement committees now have evidence to demand. Health systems that already deployed are separating from those still